Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Thiopurines and methotrexate
6 evidence topics · 4 sources
Recommendations for thiopurines and methotrexate: ACG 2025 guideline
Efficacy of thiopurines and methotrexate: ACG 2025 guideline
Recommendations for immunomodulator monotherapy and combination therapy: AGA 2024 living guideline
“5. In adult outpatients with moderate-to-severe UC, the AGA suggests AGAINST using thiopurine monotherapy for induction of remission. [Conditional recommendation, very low certainty of evidence]” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“6. In adult outpatients with moderate-to-severe UC in remission, the AGA suggests using thiopurine monotherapy, rather than no treatment, for maintenance of remission, typically induced by corticosteroids. [Conditional recommendation, low certainty of evidence]” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“7. In adult outpatients with moderate-to-severe UC, the AGA suggests AGAINST using methotrexate monotherapy, for induction or maintenance of remission. [Conditional recommendation, low certainty of evidence]” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“8. In adult outpatients with moderate-to-severe UC, the AGA suggests the use of infliximab in combination with an immunomodulator over infliximab or an immunomodulator alone. [Conditional recommendation, moderate certainty of evidence]” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“9. In adult outpatients with moderate-to-severe UC, the AGA suggests the use of adalimumab or golimumab in combination with an immunomodulator over adalimumab, golimumab or immunomodulator monotherapy. [Conditional recommendation, low certainty of evidence]” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Efficacy and harms of thiopurines and combination therapy: AGA 2024 living guideline
“On meta-analysis, thiopurines were more effective than placebo or 5-ASA for decreasing risk of disease relapse (RR, 0.61; 95% CI, 0.49–0.77) among patients with inactive UC (in remission) (eFigure 14).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“At week 16, the primary endpoint of corticosteroid-free clinical remission was achieved by 39.7% of patients receiving combination therapy compared to 22.1% of infliximab treated patients and 23.7% of azathioprine treated patients.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Short- and long-term side effects of thiopurines and methotrexate are well-recognized including risk of bone marrow suppression, hepatotoxicity (including liver fibrosis with long-term use of methotrexate), non-melanoma skin cancer and lymphoma, especially with thiopurines78.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote